AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Cytek Biosciences Inc. (CTKB)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

5.86

-0.02 (-0.34%)

At close: Jan 22, 2025, 2:40 PM

Cytek Biosciences Inc. Revenue Breakdown

Quarter	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Product Revenue	39.54M	34.12M	46.65M	38.44M	40.45M	31.17M	43.64M	36.39M	37.09M	31.48M	35.95M	32.19M	28.92M
Product Revenue Growth	+15.89%	-26.86%	+21.36%	-4.97%	+29.77%	-28.57%	+19.92%	-1.90%	+17.83%	-12.44%	+11.68%	+11.30%	n/a
Service Revenue	39.00M	36.87M	0	37.00M	9.24M	5.92M	4.70M	4.09M	3.07M	3.58M	2.94M	2.19M	12.47M
Service Revenue Growth	+5.78%	n/a	-100.00%	+300.38%	+56.20%	+25.90%	+14.95%	+33.33%	-14.43%	+21.79%	+34.65%	-82.48%	n/a

Revenue by Geography

Quarter	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Asia Pacific Revenue	31.60M	22.52M	16.08M
Asia Pacific Revenue Growth	+40.29%	+40.09%	n/a
Emea Revenue	53.18M	43.96M	36.97M
Emea Revenue Growth	+20.97%	+18.91%	n/a
Other Revenue	6.15M	2.96M	2.18M
Other Revenue Growth	+107.69%	+35.86%	n/a
United States Revenue	102.08M	94.59M	72.72M
United States Revenue Growth	+7.92%	+30.07%	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	23.37M	23.96M	23.95M	22.32M	22.43M	25.15M	23.23M	19.54M	16.85M	17.02M	14.51M	15.23M	12.24M	9.74M	8.26M	7.19M	5.53M	5.57M	6.07M
Selling, General, and Administrative Revenue Growth	-2.47%	+0.05%	+7.33%	-0.49%	-10.84%	+8.30%	+18.85%	+15.97%	-0.96%	+17.28%	-4.75%	+24.49%	+25.63%	+17.92%	+14.91%	+30.01%	-0.77%	-8.19%	n/a
Research and Development Revenue	9.88M	10.00M	9.80M	10.87M	11.17M	12.14M	9.97M	9.75M	8.65M	8.44M	8.03M	7.08M	6.08M	6.19M	5.09M	4.38M	3.38M	2.92M	3.02M
Research and Development Revenue Growth	-1.19%	+2.09%	-9.87%	-2.70%	-7.95%	+21.68%	+2.33%	+12.68%	+2.54%	+5.12%	+13.41%	+16.42%	-1.87%	+21.59%	+16.17%	+29.89%	+15.78%	-3.32%	n/a
Sales and Marketing Revenue	12.43M	12.27M	12.54M	11.56M	12.08M	14.37M	11.14M	9.03M	8.81M	8.43M	6.96M	8.30M	6.33M	5.58M	4.28M	4.56M	3.84M	3.06M	3.53M
Sales and Marketing Revenue Growth	+1.31%	-2.19%	+8.49%	-4.26%	-15.95%	+28.91%	+23.44%	+2.49%	+4.50%	+21.14%	-16.18%	+31.16%	+13.54%	+30.37%	-6.21%	+18.81%	+25.47%	-13.37%	n/a